ATA5952001A - K-clavulanat in der form eines granulates - Google Patents

K-clavulanat in der form eines granulates

Info

Publication number
ATA5952001A
ATA5952001A AT5952001A AT5952001A ATA5952001A AT A5952001 A ATA5952001 A AT A5952001A AT 5952001 A AT5952001 A AT 5952001A AT 5952001 A AT5952001 A AT 5952001A AT A5952001 A ATA5952001 A AT A5952001A
Authority
AT
Austria
Prior art keywords
clavulanat
granulate
Prior art date
Application number
AT5952001A
Other languages
English (en)
Other versions
AT413983B (de
Inventor
Otto Ing Daemon
Herwig Dr Jennewein
Thomas Lentner
Franz Xaver Ing Schwarz
Robert Veigl
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to AT5952001A priority Critical patent/AT413983B/de
Priority to PCT/EP2002/004062 priority patent/WO2002083129A2/en
Priority to AU2002315287A priority patent/AU2002315287A1/en
Priority to US10/474,480 priority patent/US20040132712A1/en
Priority to EP02740465A priority patent/EP1381362A2/de
Publication of ATA5952001A publication Critical patent/ATA5952001A/de
Priority to US11/449,041 priority patent/US20060263424A1/en
Application granted granted Critical
Publication of AT413983B publication Critical patent/AT413983B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT5952001A 2001-04-12 2001-04-12 K-clavulanat in der form eines granulates AT413983B (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT5952001A AT413983B (de) 2001-04-12 2001-04-12 K-clavulanat in der form eines granulates
PCT/EP2002/004062 WO2002083129A2 (en) 2001-04-12 2002-04-11 Pharmaceutical composition comprising clavulanic acid
AU2002315287A AU2002315287A1 (en) 2001-04-12 2002-04-11 Pharmaceutical composition comprising clavulanic acid
US10/474,480 US20040132712A1 (en) 2001-04-12 2002-04-11 Pharmaceutical compositions comprising clavulanic acid
EP02740465A EP1381362A2 (de) 2001-04-12 2002-04-11 Pharmazeutische zusammensetzung entahaltend clavulansäure
US11/449,041 US20060263424A1 (en) 2001-04-12 2006-06-07 Pharmaceutical compositions comprising clavulanic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT5952001A AT413983B (de) 2001-04-12 2001-04-12 K-clavulanat in der form eines granulates

Publications (2)

Publication Number Publication Date
ATA5952001A true ATA5952001A (de) 2005-11-15
AT413983B AT413983B (de) 2006-08-15

Family

ID=35405983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT5952001A AT413983B (de) 2001-04-12 2001-04-12 K-clavulanat in der form eines granulates

Country Status (1)

Country Link
AT (1) AT413983B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117567484A (zh) * 2023-11-16 2024-02-20 华北制药集团先泰药业有限公司 一种球状克拉维酸钾、其制备方法及复合制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080862B1 (de) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmazeutische Zubereitung die Beta-Lactam Antibiotika enthält
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
KR100499812B1 (ko) * 1997-02-14 2005-07-08 스미스클라인 비참 코포레이션 아목시실린 및 클라불라네이트를 포함하는 약제학적 제형
WO1999011261A1 (en) * 1997-08-29 1999-03-11 Dsm N.V. Granules free of excipients
AU1337999A (en) * 1997-11-17 1999-06-07 Gist-Brocades B.V. Granules comprising clavulanate and one or more excipients

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117567484A (zh) * 2023-11-16 2024-02-20 华北制药集团先泰药业有限公司 一种球状克拉维酸钾、其制备方法及复合制剂

Also Published As

Publication number Publication date
AT413983B (de) 2006-08-15

Similar Documents

Publication Publication Date Title
NO20032712D0 (no) Modifiserte uorganiske partikler
DE60215275D1 (de) Fahrradscheibenbremsnabe
DE60218084D1 (de) Markierungspartikel
DE60209540D1 (de) Zapfventil
DE50211354D1 (de) Transportwagen
DE50006169D1 (de) Schmelz-haftklebstoff in form eines granulates
DE60223044D1 (de) Granulatförmiges herbizid
DE50209384D1 (de) Einkaufswagen
DE60221187D1 (de) Bandraupe
ATA5952001A (de) K-clavulanat in der form eines granulates
NO20034295L (no) Planteoppkvikker
ITMI20020257A1 (it) Ugello rotante
FI5728U1 (fi) Hiekan jakeluyksikkö
FIU20010022U0 (fi) Hiekoituslaite
FI5193U1 (fi) Lemmikkieläinhiekka
SE0101461D0 (sv) Kameravagn
SE0201846D0 (sv) Positionskodningsmönster
FI20012324A0 (fi) Reikämuotti
SE0103273D0 (sv) Munstycke
UA5015S (uk) Емблема
UA5196S (uk) Емблема
UA5122S (uk) Емблема
UA5036S (uk) Емблема
UA5035S (uk) Емблема
UA5022S (uk) Емблема